Developed under an exclusive worldwide licence agreement with UCB, PTD802 is designed to counteract the effects of ...

An investigational drug for multiple sclerosis from Io Therapeutics has restored leg mobility and myelin nerve coatings in ...

Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

Patient enrollment is completed ahead of schedule for Contineum's Phase 2 clinical trial of PIPE-307, an oral remyelination ...

New research pinpoints genes associated with a disease seen as a major contributor to poor performance in Thoroughbred ...

Research shows that men's brains are 10-15% larger on average than women's. However, size does not impact intelligence. Men ...

Mistakes can often be the best teachers for young children. By creating a classroom environment where trying, stumbling, and trying again are celebrated, preschool educators empower children to build ...

The research report titled: “Selective retinoid X receptor agonism promotes functional recovery and myelin repair in experimental autoimmune encephalomyelitis”, G.D.S Kasheke, et al ...

Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research led by scientists at the University of ...

Pheno Therapeutics Limited has received clinical trial authorisation (CTA) from the UK’s MHRA for its lead candidate, PTD802.